BÃ‚RRX Medical, Inc. develops endoscopic treatment solutions for Barrettâ€™s esophagus and other chronic gastroenterological diseases. Barrettâ€™s is a precancerous condition of the lining of the esophagus (swallowing tube) caused by gastroesophageal reflux disease, or GERD. The companyâ€™s HALOFLEX, HALO360 and HALO90 ablation systems are designed to provide a uniform and controlled ablation effect, in order to remove diseased tissue and allow re-growth of normal cells.
A multi-center randomized, sham-controlled study, published in the New England Journal of Medicine in 2009, studied HALO radiofrequency ablation applied in the highest risk Barrettâ€™s population (those having dysplasia). The ablation group had a high rate of complete eradication of dysplasia and intestinal metaplasia and a significantly decreased rate of disease progression and cancer development, as compared to the control group. In another study... See More
Funding Rounds (1) - $15MUpdate
Founded in 1991, Frazier Healthcare Ventures is one of the leading providers of venture and growth..
Venture capital Firm
Venture Capital Firm
Early stage venture investor
Sutter Hill Ventures has financed technology-based start-ups and assisted entrepreneurs in..
Global Venture Capital Firm
540 Oakmead Parkway
Sunnyvale, CA 94085